From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70207 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2025. Written by Shiying Zhang and 2 co-authors. Institution: Institute of BioPharmaceutical Research, Liaocheng University, Liaocheng, People's Republic of China. Major MEDLINE topics: Indoleamine-Pyrrole 2,3,-Dioxygenase, Enzyme Inhibitors. Cited 1 times so far (Crossref); 31 references. Funded by: Natural Science Joint Foundation of Shandong Province, Natural Science Foundation of Shandong Province.
Abstract (original language)
Indoleamine 2,3‐dioxygenase‐1 (IDO‐1), as a crucial immunomodulatory target, plays a pivotal role in regulating immune function. In this study, the ligand‐based pharmacophore model (HDAA) and the receptor‐based pharmacophore model (HHDA) were respectively constructed, which could comprehensively reflect the spatial distribution characteristics of the core groups of IDO‐1 inhibitors. Subsequently, these pharmacophore models were utilized to guide the design of novel IDO‐1 inhibitors through a skeleton combination approach. The corresponding molecular structures were synthesized, and evaluated for their biological activities. Notably, compound 7b exhibited highly potent IDO‐1 inhibitory activity, which contributed to the body's immune activation in vivo. In summary, the study not only constructed the rational pharmacophore and docking models but also guided the development of novel IDO‐1 inhibitor skeletons, providing a promising approach to achieving immune activation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of BioPharmaceutical Research, Liaocheng University, Liaocheng, People's Republic of China.
ORCID profiles: Bin Sun
Funding
- Natural Science Joint Foundation of Shandong Province
- Natural Science Foundation of Shandong Province
Cite
APA
Zhang, S., Zhang, A., & Sun, B. (2025). From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70207
Vancouver
Zhang S, Zhang A, Sun B. From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70207
BibTeX
@article{Zhang2025,
author = {Zhang, Shiying and Zhang, Anli and Sun, Bin},
title = {From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70207}
}
EUVIMED